Home › Companies › VERA THERAPEUTICS INC. › 2024-2025
Compiled from SEC Form N-PX filings and VERA THERAPEUTICS INC.’s Form 8-K, filed May 19, 2025 (Item 5.07 on EDGAR). Page generated October 18, 2026.
Meeting of May 14, 2025: 5 items on VERA THERAPEUTICS INC.’s Form 8-K, filed May 19, 2025: 3 elected · 2 approved.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2024-2025 2025-2026
Explore VERA THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are VERA THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 19, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Marshall Fordyce, M.D. | 49,472,959 | -- | -- | 5,393,304 | 1,795,714 | 90% | Elected | — |
| Elect Director: Beth Seidenberg, M.D. | 49,033,555 | -- | -- | 5,832,708 | 1,795,714 | 89% | Elected | — |
| Elect Director: Kimball Hall | 49,366,281 | -- | -- | 5,499,982 | 1,795,714 | 90% | Elected | — |
| 2. Ratification of the Appointment of Independent Registered Public Accounting Firm | 56,649,390 | 3,556 | 9,031 | -- | -- | 99.9% | Approved | — |
| 3. Advisory Vote on Executive Compensation | 52,984,920 | 1,876,215 | 5,128 | -- | 1,795,714 | 97% | Approved | — |
Source: VERA THERAPEUTICS INC., Form 8-K, filed with the SEC on May 19, 2025 — read the filing on EDGAR.
Each item below shows how the 192 asset managers that disclosed a VERA THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of VERA THERAPEUTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 3 wordings of this item as funds reported it.
89% Majority: yes · of votes cast
Description as filed by funds: To elect the three Class I directors named below to hold office until the Company's 2028 annual meeting of stockholders: Beth Seidenberg, M.D.
VERA THERAPEUTICS INC.’s own tally for this item (“Elect Director: Beth Seidenberg, M.D.”): 49,033,555 for, 5,832,708 withheld, per its Form 8-K filed May 19, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The Company's stockholders elected the three persons listed below as Class I Directors, each to serve until the Company's 2028 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified, or, if sooner, such director's death, resignation or removal.”
Support: 89% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 58 asset managers below reported 15,788,113 for, 871,198 withheld, 179,540 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 4,697,792 | 0 | 0 | 0 | For |
| Fidelity | 2,828,244 | 0 | 0 | 0 | For |
| Vanguard | 2,782,639 | 0 | 0 | 0 | For |
| BlackRock | 1,624,532 | 0 | 0 | 0 | For |
| State Street | 907,373 | 0 | 0 | 1,086 | For |
| Federated Hermes | 788,150 | 0 | 0 | 0 | For |
| Voya | 497,234 | 0 | 0 | 0 | For |
| Charles Schwab | 422,657 | 0 | 0 | 0 | For |
| Prudential/PGIM | 408,636 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 0 | 306,623 | Withhold |
| Victory Capital | 0 | 0 | 0 | 230,613 | Withhold |
| John Hancock | 188,941 | 0 | 15,818 | 0 | Mixed |
| Equitable | 89,448 | 0 | 0 | 55,714 | Mixed |
| Bridge Builder Trust | 8,756 | 0 | 95,430 | 0 | Mixed |
| TIAA | 100,347 | 0 | 0 | 0 | For |
| Russell Investments | 80,124 | 0 | 0 | 0 | For |
| Thornburg | 67,998 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 0 | 60,758 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 60,347 | 0 | 0 | 0 | For |
| DWS | 0 | 0 | 0 | 51,343 | Withhold |
| CARILLON SERIES TRUST | 0 | 0 | 48,923 | 0 | Abstain |
| ALPS ETF Trust | 0 | 0 | 0 | 42,506 | Withhold |
| Transamerica | 39,915 | 0 | 0 | 0 | For |
| Lincoln Financial | 32,400 | 0 | 0 | 4,805 | Mixed |
| Lord Abbett | 0 | 0 | 0 | 34,880 | Withhold |
Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.
Combines 3 wordings of this item as funds reported it.
90% Majority: yes · of votes cast
Description as filed by funds: To elect the three Class I directors named below to hold office until the Company's 2028 annual meeting of stockholders: Kimball Hall
VERA THERAPEUTICS INC.’s own tally for this item (“Elect Director: Kimball Hall”): 49,366,281 for, 5,499,982 withheld, per its Form 8-K filed May 19, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The Company's stockholders elected the three persons listed below as Class I Directors, each to serve until the Company's 2028 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified, or, if sooner, such director's death, resignation or removal.”
Support: 90% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 58 asset managers below reported 15,808,365 for, 850,946 withheld, 179,540 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 4,697,792 | 0 | 0 | 0 | For |
| Fidelity | 2,828,244 | 0 | 0 | 0 | For |
| Vanguard | 2,782,639 | 0 | 0 | 0 | For |
| BlackRock | 1,624,532 | 0 | 0 | 0 | For |
| State Street | 907,373 | 0 | 0 | 1,086 | For |
| Federated Hermes | 788,150 | 0 | 0 | 0 | For |
| Voya | 497,234 | 0 | 0 | 0 | For |
| Charles Schwab | 422,657 | 0 | 0 | 0 | For |
| Prudential/PGIM | 408,636 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 0 | 306,623 | Withhold |
| Victory Capital | 0 | 0 | 0 | 230,613 | Withhold |
| John Hancock | 188,941 | 0 | 15,818 | 0 | Mixed |
| Equitable | 89,448 | 0 | 0 | 55,714 | Mixed |
| Bridge Builder Trust | 8,756 | 0 | 95,430 | 0 | Mixed |
| TIAA | 100,347 | 0 | 0 | 0 | For |
| Russell Investments | 80,124 | 0 | 0 | 0 | For |
| Thornburg | 67,998 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 0 | 60,758 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 60,347 | 0 | 0 | 0 | For |
| DWS | 0 | 0 | 0 | 51,343 | Withhold |
| CARILLON SERIES TRUST | 0 | 0 | 48,923 | 0 | Abstain |
| ALPS ETF Trust | 0 | 0 | 0 | 42,506 | Withhold |
| Transamerica | 39,915 | 0 | 0 | 0 | For |
| Lincoln Financial | 32,400 | 0 | 0 | 4,805 | Mixed |
| Lord Abbett | 0 | 0 | 0 | 34,880 | Withhold |
Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.
Combines 3 wordings of this item as funds reported it.
90% Majority: yes · of votes cast
Description as filed by funds: To elect the three Class I directors named below to hold office until the Company's 2028 annual meeting of stockholders: Marshall Fordyce, M.D.
VERA THERAPEUTICS INC.’s own tally for this item (“Elect Director: Marshall Fordyce, M.D.”): 49,472,959 for, 5,393,304 withheld, per its Form 8-K filed May 19, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The Company's stockholders elected the three persons listed below as Class I Directors, each to serve until the Company's 2028 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified, or, if sooner, such director's death, resignation or removal.”
Support: 90% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 58 asset managers below reported 15,849,445 for, 809,866 withheld, 179,540 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 4,697,792 | 0 | 0 | 0 | For |
| Fidelity | 2,828,244 | 0 | 0 | 0 | For |
| Vanguard | 2,782,639 | 0 | 0 | 0 | For |
| BlackRock | 1,624,532 | 0 | 0 | 0 | For |
| State Street | 907,373 | 0 | 0 | 1,086 | For |
| Federated Hermes | 788,150 | 0 | 0 | 0 | For |
| Voya | 497,234 | 0 | 0 | 0 | For |
| Charles Schwab | 422,657 | 0 | 0 | 0 | For |
| Prudential/PGIM | 408,636 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 0 | 306,623 | Withhold |
| Victory Capital | 0 | 0 | 0 | 230,613 | Withhold |
| John Hancock | 188,941 | 0 | 15,818 | 0 | Mixed |
| Equitable | 130,528 | 0 | 0 | 14,634 | Mixed |
| Bridge Builder Trust | 8,756 | 0 | 95,430 | 0 | Mixed |
| TIAA | 100,347 | 0 | 0 | 0 | For |
| Russell Investments | 80,124 | 0 | 0 | 0 | For |
| Thornburg | 67,998 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 0 | 60,758 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 60,347 | 0 | 0 | 0 | For |
| DWS | 0 | 0 | 0 | 51,343 | Withhold |
| CARILLON SERIES TRUST | 0 | 0 | 48,923 | 0 | Abstain |
| ALPS ETF Trust | 0 | 0 | 0 | 42,506 | Withhold |
| Transamerica | 39,915 | 0 | 0 | 0 | For |
| Lincoln Financial | 32,400 | 0 | 0 | 4,805 | Mixed |
| Lord Abbett | 0 | 0 | 0 | 34,880 | Withhold |
Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.
Combines 6 wordings of this item as funds reported it.
97% Approved · of votes cast
Description as filed by funds: TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE PROXY STATEMENT.
VERA THERAPEUTICS INC.’s own tally for this item (“3. Advisory Vote on Executive Compensation”): 52,984,920 for, 1,876,215 against — passed, per its Form 8-K filed May 19, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved, on an advisory basis, the compensation awarded to the Company's named executive officers, as disclosed in the Proxy Statement.”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 4,697,792 | 0 | 0 | 0 | For |
| Fidelity | 2,828,244 | 0 | 0 | 0 | For |
| Vanguard | 2,782,639 | 0 | 0 | 0 | For |
| BlackRock | 1,624,532 | 0 | 0 | 0 | For |
| State Street | 908,210 | 249 | 0 | 0 | For |
| Federated Hermes | 788,150 | 0 | 0 | 0 | For |
| Voya | 497,234 | 0 | 0 | 0 | For |
| Charles Schwab | 422,657 | 0 | 0 | 0 | For |
| Prudential/PGIM | 408,636 | 0 | 0 | 0 | For |
| American Century | 0 | 306,623 | 0 | 0 | Against |
| Victory Capital | 230,613 | 0 | 0 | 0 | For |
| John Hancock | 204,759 | 0 | 0 | 0 | For |
| Equitable | 145,162 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 104,186 | 0 | 0 | 0 | For |
| TIAA | 100,347 | 0 | 0 | 0 | For |
| Russell Investments | 80,124 | 0 | 0 | 0 | For |
| Thornburg | 67,998 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 60,758 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 60,347 | 0 | 0 | 0 | For |
| DWS | 51,343 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 48,923 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 42,506 | 0 | 0 | 0 | For |
| Transamerica | 39,915 | 0 | 0 | 0 | For |
| Lincoln Financial | 37,205 | 0 | 0 | 0 | For |
| Lord Abbett | 34,880 | 0 | 0 | 0 | For |
Fund voting reports, all 58 managers: 16,518,826 for, 317,141 against, 2,884 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 6,393,644 | 0 | 0 | 0 | For |
| Avoro Capital Advisors LLC | 5,202,377 | 0 | 0 | 0 | For |
| Fidelity | 2,953,085 | 0 | 0 | 0 | For |
| Commodore Capital LP | 2,225,000 | 0 | 0 | 0 | For |
| Eversept Partners, LP | 1,864,713 | 0 | 0 | 0 | For |
| State Street | 1,800,848 | 302 | 0 | 0 | For |
| Vestal Point Capital, LP | 1,680,012 | 0 | 0 | 0 | For |
| SAMLYN CAPITAL, LLC | 1,654,454 | 0 | 0 | 0 | For |
| First Light Asset Management, LLC | 1,570,885 | 0 | 0 | 0 | For |
| Kynam Capital Management, LP | 0 | 0 | 0 | 1,493,208 | Withhold |
| BlackRock | 1,469,974 | 2,291 | 0 | 0 | For |
| Sofinnova Investments, Inc. | 1,440,942 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,179,125 | 0 | 0 | 0 | For |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 833,620 | 0 | 0 | 0 | For |
| Federated Hermes | 788,150 | 0 | 0 | 0 | For |
| JENNISON ASSOCIATES LLC | 770,948 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 753,472 | 0 | 0 | 0 | For |
| Logos Global Management LP | 690,000 | 0 | 0 | 0 | For |
| Woodline Partners LP | 655,284 | 0 | 0 | 0 | For |
| Siren, L.L.C. | 655,228 | 0 | 0 | 0 | For |
| Voya | 619,675 | 0 | 0 | 0 | For |
| ORBIMED ADVISORS LLC | 481,065 | 0 | 0 | 0 | For |
| Charles Schwab | 422,684 | 0 | 0 | 0 | For |
| Rock Springs Capital Management LP | 407,164 | 0 | 0 | 0 | For |
| Candriam S.C.A. | 0 | 363,692 | 0 | 0 | Against |
Institutional-manager reports, all 152 managers: 40,413,830 for, 1,223,917 against, 1,493,208 withheld, 1,660 abstained, 150 not voted, 16,715 1 year. Showing the 25 largest; see all in the interactive database.
Combines 5 wordings of this item as funds reported it.
56% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: TO INDICATE, ON AN ADVISORY BASIS, THE PREFERRED FREQUENCY OF STOCKHOLDER ADVISORY VOTES ON THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| Vanguard | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| Federated Hermes | 0 | 0 | 0 | 0 | -- |
| Voya | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| Prudential/PGIM | 0 | 0 | 0 | 0 | -- |
| American Century | 0 | 0 | 0 | 0 | -- |
| Victory Capital | 0 | 0 | 0 | 0 | -- |
| John Hancock | 0 | 0 | 0 | 0 | -- |
| Equitable | 0 | 0 | 0 | 0 | -- |
| Bridge Builder Trust | 0 | 0 | 0 | 0 | -- |
| TIAA | 0 | 0 | 0 | 0 | -- |
| Russell Investments | 0 | 0 | 0 | 0 | -- |
| Thornburg | 0 | 0 | 0 | 0 | -- |
| AIG/SunAmerica | 0 | 0 | 0 | 0 | -- |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 0 | -- |
| DWS | 0 | 0 | 0 | 0 | -- |
| CARILLON SERIES TRUST | 0 | 0 | 0 | 0 | -- |
| ALPS ETF Trust | 0 | 0 | 0 | 0 | -- |
| Transamerica | 0 | 0 | 0 | 0 | -- |
| Lincoln Financial | 4,805 | 0 | 0 | 0 | For |
| Lord Abbett | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 58 managers: 4,805 for, 2,884 abstained, 16,829,417 1 year, 1,745 3 year. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 0 | 0 | 0 | 0 | -- |
| Avoro Capital Advisors LLC | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| Commodore Capital LP | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| Vestal Point Capital, LP | 0 | 0 | 0 | 0 | -- |
| SAMLYN CAPITAL, LLC | 0 | 0 | 0 | 0 | -- |
| First Light Asset Management, LLC | 1,570,885 | 0 | 0 | 0 | For |
| Kynam Capital Management, LP | 0 | 0 | 0 | 1,493,208 | Withhold |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| Sofinnova Investments, Inc. | 0 | 0 | 0 | 0 | -- |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 0 | 0 | 0 | 0 | -- |
| Federated Hermes | 0 | 0 | 0 | 0 | -- |
| JENNISON ASSOCIATES LLC | 0 | 0 | 0 | 0 | -- |
| PICTET ASSET MANAGEMENT SA | 0 | 0 | 0 | 0 | -- |
| Logos Global Management LP | 0 | 0 | 0 | 0 | -- |
| Woodline Partners LP | 0 | 0 | 0 | 0 | -- |
| Siren, L.L.C. | 0 | 0 | 0 | 0 | -- |
| Voya | 0 | 0 | 0 | 0 | -- |
| ORBIMED ADVISORS LLC | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | Not Voted |
| Rock Springs Capital Management LP | 0 | 0 | 0 | 0 | -- |
| Candriam S.C.A. | 0 | 0 | 0 | 0 | -- |
| Victory Capital | 0 | 0 | 0 | 0 | -- |
Institutional-manager reports, all 145 managers: 1,921,228 for, 20 against, 1,493,208 withheld, 150 not voted, 37,654,034 1 year, 21,030 3 year. Showing the 25 largest; see all in the interactive database.
99.9% Approved · of votes cast
Description as filed by funds: TO RATIFY THE SELECTION BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF KPMG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2025.
VERA THERAPEUTICS INC.’s own tally for this item (“2. Ratification of the Appointment of Independent Registered Public Accounting Firm”): 56,649,390 for, 3,556 against — passed, per its Form 8-K filed May 19, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders ratified the selection by the Audit Committee of the Company's Board of Directors of KPMG LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 58 asset managers below reported 16,835,489 for, 478 against, 2,884 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 4,697,792 | 0 | 0 | 0 | For |
| Fidelity | 2,828,244 | 0 | 0 | 0 | For |
| Vanguard | 2,782,639 | 0 | 0 | 0 | For |
| BlackRock | 1,624,532 | 0 | 0 | 0 | For |
| State Street | 908,459 | 0 | 0 | 0 | For |
| Federated Hermes | 788,150 | 0 | 0 | 0 | For |
| Voya | 497,234 | 0 | 0 | 0 | For |
| Charles Schwab | 422,657 | 0 | 0 | 0 | For |
| Prudential/PGIM | 408,636 | 0 | 0 | 0 | For |
| American Century | 306,623 | 0 | 0 | 0 | For |
| Victory Capital | 230,613 | 0 | 0 | 0 | For |
| John Hancock | 204,759 | 0 | 0 | 0 | For |
| Equitable | 145,162 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 104,186 | 0 | 0 | 0 | For |
| TIAA | 100,347 | 0 | 0 | 0 | For |
| Russell Investments | 80,124 | 0 | 0 | 0 | For |
| Thornburg | 67,998 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 60,758 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 60,347 | 0 | 0 | 0 | For |
| DWS | 51,343 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 48,923 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 42,506 | 0 | 0 | 0 | For |
| Transamerica | 39,915 | 0 | 0 | 0 | For |
| Lincoln Financial | 37,205 | 0 | 0 | 0 | For |
| Lord Abbett | 34,880 | 0 | 0 | 0 | For |
Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 63,774,158 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | T. Rowe Price | 7.37% |
| 2 | Fidelity | 4.43% |
| 3 | Vanguard | 4.36% |
| 4 | BlackRock | 2.55% |
| 5 | State Street | 1.42% |
| 6 | Federated Hermes | 1.24% |
| 7 | Voya | 0.78% |
| 8 | Charles Schwab | 0.66% |
| 9 | Prudential/PGIM | 0.64% |
| 10 | American Century | 0.48% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | T. Rowe Price | 10.03% |
| 2 | Avoro Capital Advisors LLC | 8.16% |
| 3 | Fidelity | 4.63% |
| 4 | Commodore Capital LP | 3.49% |
| 5 | Eversept Partners, LP | 2.92% |
| 6 | State Street | 2.82% |
| 7 | Vestal Point Capital, LP | 2.63% |
| 8 | SAMLYN CAPITAL, LLC | 2.59% |
| 9 | First Light Asset Management, LLC | 2.46% |
| 10 | Kynam Capital Management, LP | 2.34% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Avoro Capital Advisors LLC | 8.80% | 13G |
| T. Rowe Price | 7.46% | 13F |
| BlackRock | 6.26% | 13F |
| Deep Track Capital, LP | 6.15% | 13G |
| Deerfield Mgmt, L.P. | 5.25% | 13G |
| FMR (Fidelity) | 5.07% | 13F |
| Vanguard Group | 4.58% | 13F |
| Sofinnova Venture Partners X, L.P. ("SVP X") | 4.38% | 13D |
| State Street | 3.27% | 13F |
| Point72 Asset Management, L.P. | 1.93% | 13G |
Percentages above are of 63,774,158 shares outstanding, as reported by VERA THERAPEUTICS INC. on its Form 10-Q dated May 1, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from VERA THERAPEUTICS INC.’s 10-Q dated May 1, 2025. This page is a static snapshot rebuilt weekly on October 18, 2026; a live search always shows the current data.
At VERA THERAPEUTICS INC.'s shareholder meeting held May 14, 2025, in the 2024-2025 proxy season, 192 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,578 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS… — VERA THERAPEUTICS INC.'s filing reports the proposal as approved, with 97% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: VERA THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 19, 2025.
VERA THERAPEUTICS INC. proxy season coverage: 2024-2025 (this page) · 2025-2026.
Download data (CSV): ballot items · votes by manager · column guide.